Natural killer cells play a key role in the antitumor immunity generated by chaperone-rich cell lysate vaccination

被引:29
|
作者
Zeng, Yi [1 ]
Chen, Xinchun [1 ]
Larmonier, Nicolas [1 ]
Larmonier, Claire [1 ]
Li, Gang [1 ]
Sepassi, Marjan [1 ]
Marron, Marilyn [1 ]
Andreansky, Samita [1 ]
Katsanis, Emmanuel [1 ]
机构
[1] Univ Arizona, Dept Pediat, Steele Childrens Res Ctr, Tucson, AZ 85724 USA
关键词
chaperone/heat shock proteins; NK cell; CML; HUMAN NK CELLS; NF-KAPPA-B; IFN-GAMMA PRODUCTION; INTERFERON-GAMMA; DENDRITIC CELLS; INNATE RESISTANCE; SIGNALING PATHWAY; TUMOR-CELLS; ACTIVATION; MICE;
D O I
10.1002/ijc.22150
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor derived chaperone-rich cell lysate (CRCL) when isolated from tumor tissues is a potent vaccine that contains at least 4 of the highly immunogenic heat shock proteins (HSP) such as HSP70, HSP90, glucose related protein 94 and calreticulin. We have previously documented that CRCL provides both a source of tumor antigens and danger signals triggering dendritic cell (DC) activation. Immunization with tumor derived CRCL elicits tumor-specific T cell responses leading to tumor regression. In the current study, we further dissect the mechanisms by which CRCL simulates the immune system, and demonstrate that natural killer (NK) cells are required for effective antitumor effects to take place. Our results illustrate that CRCL directly stimulates proin-flammatory cytokine and chemokine production by NK cells, which may lead to activation and recruitment of macrophages at the tumor site. Thus, this report provides further insight into the function of CRCL as an immunostimulant against cancer. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:2624 / 2631
页数:8
相关论文
共 31 条
  • [21] Endogenous natural killer cells do not play a role in antitumor effects induced by interleukin-2 in a syngeneic rat colon tumor model
    Hagenaars, M
    Ensink, NG
    Eggermont, AMM
    van der Velde, EA
    van de Velde, CJH
    Fleuren, GJ
    Kuppen, PJK
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 48 (10) : 561 - 568
  • [22] Inhibition of antitumor immunity by invariant natural killer T cells in a T-cell lymphoma model in vivo (vol 118, pg 3045, 2006)
    Renukaradhya, G. J.
    Sriram, V
    Du, W.
    Gervay-Hague, J.
    Van Kaer, L.
    Brutkiewicz, R. R.
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (09) : 2246 - 2246
  • [23] A key ingredient for priming killer T cells WDFY4 protein controls the generation of antiviral and antitumor CD8+T cell immunity
    Barbet, Gaetan
    Blander, J. Magarian
    SCIENCE, 2018, 362 (6415) : 641 - 642
  • [24] Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy
    Kharkwal, Shalu Sharma
    Johndrow, Christopher T.
    Veerapen, Natacha
    Kharkwal, Himanshu
    Saavedra-Avila, Noemi A.
    Carreno, Leandro J.
    Rothberg, Samantha
    Zhang, Jinghang
    Garforth, Scott J.
    Jervis, Peter J.
    Zhang, Lianjun
    Donda, Alena
    Besra, Amareeta K.
    Cox, Liam R.
    Almo, Steven C.
    Howell, Alan
    Evans, Elizabeth E.
    Zauderer, Maurice
    Besra, Gurdyal S.
    Porcelli, Steven A.
    CANCER RESEARCH, 2021, 81 (07) : 1788 - 1801
  • [25] Key Role of the CD56lowCD16low Natural Killer Cell Subset in the Recognition and Killing of Multiple Myeloma Cells
    Vulpis, Elisabetta
    Stabile, Helena
    Soriani, Alessandra
    Fionda, Cinzia
    Petrucci, Maria Teresa
    Mariggio, Elena
    Ricciardi, Maria Rosaria
    Cippitelli, Marco
    Gismondi, Angela
    Santoni, Angela
    Zingoni, Alessandra
    CANCERS, 2018, 10 (12):
  • [26] Role of natural killer and NK1(+) T-cells in regulating cell-mediated immunity during Toxoplasma gondii infection
    Denkers, EY
    Sher, A
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : 699 - 703
  • [27] Vaccine Based on Dendritic Cells Electroporated with an Exogenous Ovalbumin Protein and Pulsed with Invariant Natural Killer T Cell Ligands Effectively Induces Antigen-Specific Antitumor Immunity
    Watanabe, Akihiro
    Yamashita, Kimihiro
    Fujita, Mitsugu
    Arimoto, Akira
    Nishi, Masayasu
    Takamura, Shiki
    Saito, Masafumi
    Yamada, Kota
    Agawa, Kyosuke
    Mukoyama, Tomosuke
    Ando, Masayuki
    Kanaji, Shingo
    Matsuda, Takeru
    Oshikiri, Taro
    Kakeji, Yoshihiro
    CANCERS, 2022, 14 (01)
  • [28] Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity
    Liu, YQ
    Huang, H
    Chen, Z
    Zong, L
    Xiang, J
    JOURNAL OF GENE MEDICINE, 2003, 5 (08): : 668 - 680
  • [29] THE ROLE OF LY-5.1 IN MURINE NATURAL-KILLER (NK) CELL-MEDIATED-IMMUNITY AGAINST YAC-1 TARGET-CELLS
    ZAROUKIAN, M
    ESSELMAN, W
    MILLER, H
    FEDERATION PROCEEDINGS, 1983, 42 (03) : 677 - 677
  • [30] Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vγ/Vδ2 T cells in tumor immunity
    Fisch, P
    Meuer, E
    Pende, D
    Rothenfusser, S
    Viale, O
    Kock, S
    Ferrone, S
    Fradelizi, D
    Klein, G
    Moretta, L
    Rammensee, HG
    Boon, T
    Coulie, P
    van der Bruggen, P
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) : 3368 - 3379